Clinical Characteristics | Variables | Available data (n) | n (%) |
---|---|---|---|
Age, years | 20–30/30–40/40–50/50–60/60–70/ > 70 | 21 | 2(9.52%)/2(9.52%)/7(33.3%)/5(23.8%)/4(19.0%)/5(23.8%) |
Gender | Male/Female | 21 | 18(85.7%)/3(14.3%) |
TNM | T1bN0M0/T2N0M0/T4N0M0/T4N1M1 | 11 | 6(54.5%)/1(9.0%)/3(27.3%)/1(9.0%) |
BCLC | 0/A/B/C | 14 | 1(7.1%)/7(50.0%)/2(14.3%)/4(28.6%) |
Immunohistochemistry | GPC3(+)/ GPC3(−) | 13 | 7(53.8%)/6(46.2%) |
Hep-1(+)/ Hep-1(−)/None | 18 | 11(61.1%)/1(5.5%)/6(33.3%) | |
CD34(+)/CD34(−)/None | 18 | 10(55.6%)/2(11.1%)/6(33.3%) | |
HBsAg(+)/HBsAg(−) | 18 | 14(77.8%)/4(22.2%) | |
Arginase(+)/Arginase(−)/None | 18 | 8(44.4%)/1(5.5%)/9(50.0%) | |
AMACR(+)/AMACR(−)/None | 18 | 8(44.4%)/5(27.8%)/5(27.8%) | |
CK7(+)/CK7(−) | 18 | 1(5.5%)/17(94.4%) | |
GS(+)/GS(−) | 18 | 2(11.1%)/16(88.9%) | |
HSP70(+)/HSP70(−) | 18 | 11(61.1%)/7(38.9%) | |
CD10(+)/CD10(−) | 18 | 2(11.1%)/16(88.9%) | |
CK19(+)/CK19(−) | 18 | 1(5.5%)/17(94.4%) | |
CD31(+)/None | 18 | 9(50.0%)/9(50.0%) |